These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


320 related items for PubMed ID: 2509396

  • 21. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
    Robison WG.
    Adv Exp Med Biol; 1988; 246():365-72. PubMed ID: 3150650
    [Abstract] [Full Text] [Related]

  • 22. Increased numbers of caveolae in retinal endothelium and pericytes in hypertensive diabetic rats.
    Hillman N, Cox S, Noble AR, Gallagher PJ.
    Eye (Lond); 2001 Jun; 15(Pt 3):319-25. PubMed ID: 11450729
    [Abstract] [Full Text] [Related]

  • 23. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus.
    Hainsworth DP, Katz ML, Sanders DA, Sanders DN, Wright EJ, Sturek M.
    Comp Med; 2002 Dec; 52(6):523-9. PubMed ID: 12540165
    [Abstract] [Full Text] [Related]

  • 24. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN, Amin R, Kennedy A, Hohman TC.
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [Abstract] [Full Text] [Related]

  • 25. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice.
    Steinle JJ, Kern TS, Thomas SA, McFadyen-Ketchum LS, Smith CP.
    Exp Eye Res; 2009 Jun; 88(6):1014-9. PubMed ID: 19176214
    [Abstract] [Full Text] [Related]

  • 26. Fenestrated subendothelial basement membranes in human retinal capillaries.
    Carlson EC.
    Invest Ophthalmol Vis Sci; 1989 Sep; 30(9):1923-32. PubMed ID: 2777512
    [Abstract] [Full Text] [Related]

  • 27. Freeze-fracture and lanthanum studies of the retinal microvasculature in diabetic rats.
    Caldwell RB, Slapnick SM.
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1610-9. PubMed ID: 1532791
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Aldose reductase activity in retinal and cerebral microvessels and cultured vascular cells.
    Kennedy A, Frank RN, Varma SD.
    Invest Ophthalmol Vis Sci; 1983 Sep; 24(9):1250-8. PubMed ID: 6411648
    [Abstract] [Full Text] [Related]

  • 30. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [Abstract] [Full Text] [Related]

  • 31. Amelioration of diabetes-like retinal changes in galactose-fed dogs.
    Kador PF, Takahashi Y, Sato S, Wyman M.
    Prev Med; 1994 Sep; 23(5):717-21. PubMed ID: 7845946
    [Abstract] [Full Text] [Related]

  • 32. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
    Akagi Y, Terubayashi H, Ikebe H, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice.
    Grant MB, Spoerri PE, Player DW, Bush DM, Ellis EA, Caballero S, Robison WG.
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2296-302. PubMed ID: 10892876
    [Abstract] [Full Text] [Related]

  • 35. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG, Jacot JL, Glover JP, Basso MD, Hohman TC.
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy.
    Sredy J, Sawicki DR, Notvest RR.
    J Diabet Complications; 1991 Sep; 5(1):42-7. PubMed ID: 1830318
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.